BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ORION Biotech Catalyst Calendar//company//EN
CALSCALE:GREGORIAN
X-WR-CALNAME:ORION — CORT stated timing
X-WR-CALDESC:Exact dates CORT stated in SEC filings\, quoted as written\, w
 ith SEC links. No forecasts.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:orion-event-FDA20261030-CORT-FDA-DECISION@orionbiotechai.com
SEQUENCE:2
DTSTAMP:20261029T000000Z
LAST-MODIFIED:20261029T000000Z
DTSTART;VALUE=DATE:20261217
DTEND;VALUE=DATE:20261218
SUMMARY:CORT relacorilant: FDA decision\, “December 17\, 2026”
DESCRIPTION:CORCEPT THERAPEUTICS INC (CORT)\, relacorilant: PDUFA target ac
 tion date.\nCompany wording\, as written: “Relacorilant for patients wit
 h Cushing’s syndrome – New Drug Application for relacorilant resubmitt
 ed with a Prescription Drug User Fee Act (PDUFA) date of December 17\, 202
 6”\nStated period: “December 17\, 2026”.\nFiled 2026-07-29\, SEC For
 m 8-K\, EX-99.1.\nSEC filing: https://www.sec.gov/Archives/edgar/data/1088
 856/000162828026050607/cort072926ex991pressrelease.htm\nORION page: https:
 //www.orionbiotechai.com/company/CORT?src=ics\nORION records what the comp
 any wrote. It is not a forecast.
URL:https://www.orionbiotechai.com/company/CORT?src=ics
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR